Abattis Bioceuticals Corp. is looking to raise C$6 million via an equity offering of 13,953,488 units priced at 43 cents each.
Each unit is made up of 1 common share and 0.5 of a purchase warrant. Each whole warrant is exercisable into 1 common share for 65 cents apiece.
The Canadian biotechnology company may sell up to an additional 15% of the shares offered.
The company will use proceeds from the private placement for strategic investments, deployment of extraction equipment and general working capital.
